Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)

NCT00119717 is registered in ClinicalTrials.gov with CoAxia as lead sponsor.

NCT NCT00119717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00119717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
Lead sponsor
CoAxia
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
July 31, 2010
Enrollment
515 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident